Page 8 - Robert Berman News Today

Robert Berman, together with language expert Christy Bandak as editor, have written a book full of idioms and explain why there is a whole chapter on fingers

Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Concludes Successful VenoValve Pre-IDE Meeting with FDA IRVINE, CA / ACCESSWIRE / January 12, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that it has successfully concluded its VenoValve Pre-IDE meeting with the U.S. Food and Drug Administration ("FDA"). Topics presented at the meeting included the background and clinical need for the VenoValve, pr...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Oklahoma Kicks Off Use of Rekor’s Vehicle Recognition Technology to Power Uninsured Vehicle ... Rekor SystemsJanuary 7, 2021 GMT Company launches state-wide program in just 61 days Program identifies non-compliant vehicles, connects motorists to affordable insurance COLUMBIA, Md., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Rekor Systems, Inc., (NASDAQ: REKR) (“Rekor”) (the “Company”) a Maryland-based...

Rekor Launches Rekor Go Mobile App on iOS and Android App Requires no Cellular Service or Wi-fi Connection Thursday, December 17, 2020 9:51 AM Rekor Systems, Inc., (REKR) (“Rekor”) (the “Company”) a Maryland-based company providing real-time roadway intelligence through AI-driven decisions, today announced the launch of Rekor Go, an application that brings the power of accurate vehicle recognition to the mobile devices of a broad array of commercial users. The app turns a smartphone in...

Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Reports Two CoreoGraft Patients Have Reached 30 Day Milestone IRVINE, CA / ACCESSWIRE / December 16, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that two patients who have undergone heart bypass surgeries utilizing HJLIs CoreoGraft have reached the 30-day milestone and are reported to have good cardiac function. The first two CoreoGraft surgeries w...

Share: IRVINE, CA / ACCESSWIRE / December 15, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the final aggregated data for the VenoValve first-in-human trial shows significant improvements in all study endpoints. For the eleven patients in the first-in-human study, reflux (the backwards flow of blood) improved an average of 54%, disease manifestations as measured by a venous clin...

Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces Significant Improvements in all Study Endpoints For Final VenoValve First-in-Human Data IRVINE, CA / ACCESSWIRE / December 15, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the final aggregated data for the VenoValve first-in-human trial shows significant improvements in all study endpoints. For the eleven patients in the...